Asahi Kasei Ventures took part in a $70m round for food waste technology provider Hazel Technologies while Zoll Medical Corporation bought portfolio company Respicardia.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Sony has invested a further $200m in the Fortnite and Gears of War developer, at a $28.7bn valuation representing a 66% increase from last August.

The artificial intelligence technology developer doubled its valuation to $5.1bn in a round led by SoftBank Vision Fund 2 and backed by GV and Intel Capital.

SoftBank Vision Fund 2 led the physical training technology provider’s latest round, which took its total funding to $300m.

Cambrian Biopharma, LG, GlaxoSmithKline, Novo and Takeda all invested in the cell therapy developer to help it close its series C round.

Taiho has reupped its commitment to the venture firm’s second fund, which is also backed by EA Pharma and Senju and which has closed at $95m.

UGA spinout Aruna Bio is working on a treatment for neurodegenerative diseases such as Parkinson’s and multiple sclerosis.

American Family and Cox Enterprises have helped the digital insurance provider reach a unicorn valuation and take its overall funding to $329m.

Vision Fund 2 participated in a series B round for the gene therapy developer, formed through the 2019 merger of Torque Therapeutics and Cogen Immune Medicine.